Text-only version of this email
Blueprint Medicines Corp
October 30, 2024 7:00 AM EDT Blueprint Medicines Reports Third Quarter 2024 Results and Raises AYVAKIT®/AYVAKYT® (avapritinib)
Full Year Revenue Guidance
View this release →
Or click here to view all releases.
Show all